LEGN
Legend Biotech (LEGN)
$34
About Legend Biotech (LEGN)
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Details
Daily high
$29.46
Daily low
$28.10
Price at open
--
52 Week High
$45.30
52 Week Low
$16.24
Market cap
5.4B
Dividend yield
0.00%
Volume
1,336
Avg. volume
3.6M
P/E ratio
-21.57
Legend Biotech News
Details
Daily high
$29.46
Daily low
$28.10
Price at open
--
52 Week High
$45.30
52 Week Low
$16.24
Market cap
5.4B
Dividend yield
0.00%
Volume
1,336
Avg. volume
3.6M
P/E ratio
-21.57